Edgewell Personal Care Company heads into its May 6 Q2 earnings report carrying the heaviest short interest load it has seen in months — and the stock just fell another 5% on the week, deepening a setup worth watching closely.
The short story here is the most notable angle. Short interest climbed from roughly 9.6% of the float in late March to a peak near 12.9% by mid-April — a 36% jump over thirty days. That is a meaningful accumulation. The position has eased only marginally since then, finishing the week near 12.1%, still more than three percentage points above where it was a month ago. Days to cover under FINRA data is 10, meaning shorts would need nearly two weeks of average volume to fully exit. Despite that elevated positioning, the borrow market shows no strain: cost to borrow is just 0.47%, barely changed on the week, and availability is extremely loose at over 600% of short interest. That combination — high SI, low CTB, ample supply — suggests the short book is positioning on fundamentals rather than riding a technical squeeze.
Options paint a slightly less bearish picture than they did a few weeks ago. The put/call ratio has fallen to 1.60 from above 2.0 in late March, now sitting just below its 20-day average of 1.69. That drift lower is not dramatic, but it does mean investors are buying fewer puts relative to calls than they were. The z-score of -0.71 confirms options positioning has become less defensive at the margin, even as the stock itself continued to slide.
The Street is cautious but not uniformly bearish. The most recent analyst moves — both from February, following last quarter's results — saw Barclays lift its target to $21 and Wells Fargo nudge to $22, while keeping ratings unchanged at Equal-Weight and Overweight respectively. The mean target across analysts is around $24, roughly 10% above the current $21.75 close. Earlier cuts from Morgan Stanley, Barclays, and RBC in late 2025 had dragged targets lower after a weaker North American revenue trend; the modest February lifts suggest the worst of those estimate reductions may be behind it. On valuation, EV/EBITDA has compressed to 8.8x, down modestly over the past month, and the P/E is near 11x — undemanding multiples for a consumer staples name if the top line stabilises. The EPS surprise factor score ranks in the 97th percentile, meaning the company has consistently beaten estimates, which at least offers some offset to the bearish positioning.
Institutional ownership is concentrated and broadly stable. BlackRock is the top holder at 15.3% of shares, with Brandes Investment Partners close behind at 13.1% as of December. Norges Bank added over 1.2 million shares in Q4 2025 and Rubric Capital Management entered the register with just over one million shares in the same period — both suggesting at least some longer-duration conviction buyers have been active near these levels.
The Q2 print on May 6 is the near-term focal point. Last quarter the stock fell just over 1% on the day but recovered to a 6.5% gain over the following five days — a pattern that rewarded those who held through the initial reaction. With short interest elevated at 12% of float, the May 6 print becomes less a debate about whether Edgewell is growing and more a test of whether tariff headwinds and North American volume pressure are in line with what shorts have already priced in.
See the live data behind this article on ORTEX.
Open EPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
